Abstract
A solution to the ongoing global COVID-19 pandemic is the mass production of vaccines. Safe and effective vaccine development is one avenue to combat the ongoing pandemic. However, although the WHO has approved several vaccines for emergency use, developing and least-developed countries are still in an unfavorable position as they cannot secure those vaccines. Technology transfer initiatives are one solution to speed up the production process. Nevertheless, this proposal is still a work in progress. Despite the willingness of developing and least developed countries to manufacture the vaccine, several challenges, such as infrastructure and intellectual property rights, are hindering the technology transfer process.
 Keywords: technology transfer, COVID-19, vaccine development, vaccine inequality
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
